MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus

Acta Histochemica

Volumn 116, Issue 5, 2014, Pages 891-897

  Liu, Dongmei ^a   Zhao, Haiyan ^a   Zhao, Shuai ^a   Wang, Xiaofei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gene ontology analysis; Microarray; MiRNA; Pathway analysis; SLE

Indexed keywords

MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; WNT PROTEIN; TRANSCRIPTOME;

ADULT; ARTICLE; CASE REPORT; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MICROARRAY ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; UPREGULATION; GENETICS; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84904057971     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.02.009     Document Type: Article

References (32)

1. Allegra A., Alonci A., Campo S., Penna G., Petrungaro A., Gerace D., et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012, 41:1897-1912.
2. Ameres S.L., Zamore P.D. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 2013, 14:475-488.
3. Bertsias G.K., Salmon J.E., Boumpas D.T. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010, 69:1603-1611.
4. Bushati N., Cohen S.M. microRNA functions. Annu Rev Cell Dev Biol 2007, 23:175-205.
5. Carlsen A.L., Schetter A.J., Nielsen C.T., Lood C., Knudsen S., Voss A., et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 2013, 65:1324-1334.
6. Chen L., Zhang J., Feng Y., Li R., Sun X., Du W., et al. MiR-410 regulates MET to influence the proliferation and invasion of glioma. Int J Biochem Cell Biol 2012, 44:1711-1717.
7. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16:939-946.
8. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
9. Gattolliat C.H., Thomas L., Ciafre S.A., Meurice G., Le Teuff G., Job B., et al. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 2011, 105:1352-1361.
10. Gurevitz S.L., Snyder J.A., Wessel E.K., Frey J., Williamson B.A. Systemic lupus erythematosus: a review of the disease and treatment options. Consult Pharm 2013, 28:110-121.
11. Hai-yan W., Yang L., Mei-hong C., Hui Z. Expression of microRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011, 33:185-188.
12. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
13. Jin N., Wang Q., Zhang X., Jiang D., Cheng H., Zhu K. The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus. Int Immunopharmacol 2011, 11:1319-1326.
14. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006, 34:D354-D357.
15. Kirou K.A., Gkrouzman E. Anti-interferon alpha treatment in SLE. Clin Immunol 2013, 148:303-312.
16. Kow N.Y., Mak A. Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythematosus. Clin Dev Immunol 2013, 2013:245928.
17. Lashine Y.A., Seoudi A.M., Salah S., Abdelaziz A.I. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol 2011, 29:351-357.
18. Liu C.G., Calin G.A., Volinia S., Croce C.M. MicroRNA expression profiling using microarrays. Nat Protoc 2008, 3:563-578.
19. Luo X., Yang W., Ye D.Q., Cui H., Zhang Y., Hirankarn N., et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 2011, 7:e1002128.
20. Miao C.G., Yang Y.Y., He X., Huang C., Huang Y., Zhang L., et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal 2013, 25:1828-1836.
21. Murphy G., Lisnevskaia L., Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet 2013, 382:809-818.
22. Ringner M. What is principal component analysis?. Nat Biotechnol 2008, 26:303-304.
23. Ronnblom L., Alm G.V., Eloranta M.L. The type I interferon system in the development of lupus. Semin Immunol 2011, 23:113-121.
24. Shen N., Liang D., Tang Y., de Vries N., Tak P.P. MicroRNAs - novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 2012, 8:701-709.
25. Shirota Y., Yarboro C., Fischer R., Pham T.H., Lipsky P., Illei G.G. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann Rheum Dis 2013, 72:118-128.
26. Stagakis E., Bertsias G., Verginis P., Nakou M., Hatziapostolou M., Kritikos H., et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011, 70:1496-1506.
27. Tveita A.A., Rekvig O.P. Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development. Arthritis Rheum 2011, 63:513-522.
28. Wang G., Tam L.S., Kwan B.C., Li E.K., Chow K.M., Luk C.C., et al. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 2012, 31:435-440.
29. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
30. Xiong W., Lahita R.G. Pragmatic approaches to therapy for systemic lupus erythematosus. Nat Rev Rheumatol 2014, 10:97-107.
31. Zhao S., Wang Y., Liang Y., Zhao M., Long H., Ding S., et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011, 63:1376-1386.
32. Zhao X., Tang Y., Qu B., Cui H., Wang S., Wang L., et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 2010, 62:3425-3435.